WallStSmart
MOLN

Molecular Partners AG ADR

NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY

$3.84
+2.81% today

Updated 2026-06-03

Market cap
$153.79M
P/E ratio
P/S ratio
156.56x
EPS (TTM)
$-1.96
Dividend yield
52W range
$3 – $5
Volume
0.0M

Molecular Partners AG ADR (MOLN) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2013201420152016201720182019202020212022202320242025
Total assets$110.11M$194.02M$219.40M$184.10M$144.42M$155.16M$104.94M$187.55M$172.67M$262.26M$198.35M$158.53M$102.11M
Cash & equivalents$96.13M$188.38M$195.37M$149.74M$131.32M$98.96M$75.71M$133.72M$71.81M$87.95M$67.31M$63.87M$82.65M
Current assets$107.79M$191.96M$216.86M$181.56M$142.53M$153.32M$99.92M$177.81M$164.19M$254.75M$192.46M$154.28M$96.88M
Total liabilities$61.80M$45.54M$67.60M$48.30M$27.69M$63.45M$50.80M$80.33M$65.38M$27.09M$21.92M$16.89M$21.77M
Current liabilities$22.74M$22.10M$26.45M$15.77M$14.14M$36.87M$28.61M$57.67M$46.87M$17.25M$14.42M$10.79M$11.03M
Long-term debt
Shareholder equity$48.32M$148.48M$151.79M$135.79M$116.73M$91.70M$54.14M$107.22M$107.29M$235.17M$176.43M$141.64M$80.33M
Retained earnings$-14.05M$-17.35M$-18.02M$-37.27M$-60.72M$-89.86M$-130.87M$-195.17M$-250.95M$-127.78M$-191.75M$-246.29M$-311.75M
Accounts receivable$11.54M$2.85M$1.34M$844000.00$1.15M$51.62M$2.55M$2.84M$25.73M$1.70M$1.75M$286000.00$1.91M
Inventory$-11.54M$379679.00$126478.00$-844000.00$-9.43M$-2.29M$-486000.00$-199000.00$2.00
Goodwill

Frequently asked questions

How much free cash flow does MOLN generate?

MOLN produced $-51.97M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MOLN's balance sheet healthy?

MOLN holds $82.65M in cash and equivalents against — in long-term debt, on $80.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.